Ozone Pharmaceuticals Limited - Company Profile

Q: Who are the current directors of Ozone Pharmaceuticals Limited?

The current directors of Ozone Pharmaceuticals Limited are Geeta Sehgal, Anju Bala, Akarsh Kashyap, Dipak Kumar Singh, Anupam Verma, Subhash Chander Sehgal, Neelam Oberoi, Surender Pal Mahi.

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1991.

1991 New Delhi, Delhi, India Active

Last Updated: December 18, 2025

Access Report

About Ozone Pharmaceuticals Limited

Ozone Pharmaceuticals Limited, a active public limited company, was established on 13 March 1991 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999DL1991PLC043461. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.36 Cr.

Formerly known as Ozone Export India Private Limited, Ozone Pharmaceuticals Private Limited. It upholds a compliant status. Employing 2,164 professional, Its leadership includes Geeta Sehgal (Director), Anju Bala (Director), Akarsh Kashyap (Director). Past directors included Geeta Sehgal, Vinod Kapur, Devender Dogra. It holds ₹94.71 Cr open charges and ₹59.22 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1, Lsc, Block, A-3, Janakpuri, New Delhi, Delhi, 110058.

Company Details

CIN/LLPIN
U99999DL1991PLC043461
Registration Number
043461
Incorporation Date
13 March 1991
Authorized Capital
₹7.50 Cr
Paid-Up Capital
₹5.36 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 7.50 Cr as on 18-12-2025
Paid Up Capital ₹ 5.36 Cr as on 18-12-2025
Company Age 34 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 94.71 Cr as on 18-12-2025
Satisfied Charges ₹ 59.22 Cr as on 18-12-2025
Revenue Growth **** 12.80% (FY 2023)
Profit Growth **** -69.73% (FY 2023)
Ebitda **** -22.94% (FY 2023)
Net Worth 1.65% (FY 2023)
Total Assets **** 5.47% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Ozone Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ozone Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Geeta Sehgal	Director	30 Dec 2009	Current
Anju Bala	Director	21 Sep 2022	Current
Akarsh Kashyap	Director	19 Oct 2015	Current
Dipak Kumar Singh	Director	01 Feb 2016	Current
Anupam Verma	Whole-Time Director	01 Feb 2021	Current
Subhash Chander Sehgal	Managing Director	21 Jun 1996	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	29 Dec 2014	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past
Pramod Abcsdd	Director	09 Apr 2015	Past
Pramod Abcsdd	Director	24 Jul 2020	Past
Pramod Abcsdd	Cfo(Kmp)	18 Apr 2019	Past
Pramod Abcsdd	Director	11 Apr 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ozone Pharmaceuticals.

Ozone Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.8% increase. The company also saw a substantial fall in profitability, with a 69.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.65%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

12.80%

*******

Revenue from Operations

*******

13.47%

*******

Total Assets

*******

5.47%

*******

Profit or Loss

*******

-69.73%

*******

Net Worth

*******

1.65%

*******

EBITDA

*******

-22.94%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ozone Pharmaceuticals?

In 2024, Ozone Pharmaceuticals had a promoter holding of 93.30% and a public holding of 6.70%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹947,079,000.00

Satisfied Charges

₹592,214,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 33.95 Cr
Yes Bank Limited : 26.92 Cr
Others : 25.31 Cr
Icici Bank Limited : 7.54 Cr
Axis Bank Limited : 0.98 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Nov 2024	Others	₹6.85 Cr	Open
14 Jun 2024	Hdfc Bank Limited	₹3.10 M	Open
08 Feb 2024	Hdfc Bank Limited	₹1.29 Cr	Open
29 Nov 2023	Axis Bank Limited	₹7.65 M	Open
04 Sep 2023	Yes Bank Limited	₹25.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Ozone Pharmaceuticals?

Ozone Pharmaceuticals has a workforce of 2164 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ozone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ozone Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ozone Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Ozone Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Director Appointment

Surender Pal Mahi was appointed as a Additional Director was appointed as a Additional Director on 26 May 2025 & has been associated with this company since 8 months 22 days . was recorded as a recent event.
26 May 2025
Balance Sheet

Ozone Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 32.00 Cr registered on 28 Feb 2022 with Charge ID 100559714 was modified on 30 Jan 2025. was documented.
30 Jan 2025
Charges

Progress on A charge with Others amounted to Rs. 6.85 Cr with Charge ID 101007173 was registered on 22 Nov 2024. was documented.
22 Nov 2024
Charges

The activity A charge with Yes Bank Limited of Rs. 25.00 Cr registered on 04 Sep 2023 with Charge ID 100837879 was modified on 20 Sep 2024. was completed.
20 Sep 2024

Explore recent activity and updates - View Recent Activity